1997
Peripheral vascular disease evaluated with reduced-dose gadolinium-enhanced MR angiography.
Rofsky N, Johnson G, Adelman M, Rosen R, Krinsky G, Weinreb J. Peripheral vascular disease evaluated with reduced-dose gadolinium-enhanced MR angiography. Radiology 1997, 205: 163-9. PMID: 9314979, DOI: 10.1148/radiology.205.1.9314979.Peer-Reviewed Original ResearchConceptsPeripheral vascular diseaseGadolinium-enhanced MR angiographyDigital subtraction angiographyVascular diseaseMR angiographyGadopentetate dimeglumineLower extremity peripheral vascular diseasePeripheral vascular areasExtent of diseaseMR angiography findingsGadolinium-enhanced magnetic resonance angiographyMagnetic resonance angiographyConventional digital subtraction angiographyStandard of referenceAngiography findingsMost patientsLess stenosisTreatment optionsLower extremitiesDSA findingsVascular areaAngiographyAnatomic segmentsAnatomic areasContrast materialSuppression of venous signal in time-of-flight MR angiography of the lower extremities after administration of gadopentetate dimeglumine.
Rofsky N, Purdy D, Johnson G, DeCorato D, Earls J, Krinsky G, Weinreb J. Suppression of venous signal in time-of-flight MR angiography of the lower extremities after administration of gadopentetate dimeglumine. Radiology 1997, 202: 177-82. PMID: 8988209, DOI: 10.1148/radiology.202.1.8988209.Peer-Reviewed Original ResearchConceptsGadopentetate dimeglumineLower extremitiesMR angiographyPeripheral vascular diseaseVenous signalDistal lower extremityMR angiogramsGadopentetate dimeglumine administrationStudent's t-testFlight MR angiographyAdult patientsAngiography timeVascular diseaseFlight MR angiogramsGradient echo sequenceAdministrationDimegluminePatientsAngiographyT-testAngiogramsExtremitiesMuscle tissueVenous suppressionImaging sectionsThoracic aorta: comparison of gadolinium-enhanced three-dimensional MR angiography with conventional MR imaging.
Krinsky G, Rofsky N, DeCorato D, Weinreb J, Earls J, Flyer M, Galloway A, Colvin S. Thoracic aorta: comparison of gadolinium-enhanced three-dimensional MR angiography with conventional MR imaging. Radiology 1997, 202: 183-93. PMID: 8988210, DOI: 10.1148/radiology.202.1.8988210.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAorta, ThoracicAortic Aneurysm, ThoracicAortic CoarctationAortic DiseasesAortic DissectionContrast MediaDrug CombinationsFemaleGadoliniumGadolinium DTPAHumansImage Processing, Computer-AssistedInfant, NewbornMagnetic Resonance AngiographyMagnetic Resonance ImagingMaleMeglumineMiddle AgedOrganometallic CompoundsPentetic AcidRetrospective StudiesConceptsThoracic aortic diseaseThree-dimensional MR angiographyConventional MR imagingMR angiographyIntramural hematomaAortic dissectionAortic diseaseVessel diseaseMR imagingFindings of surgeryChronic aortic dissectionThoracic MR imagingComparison of gadoliniumMagnetic resonance angiographyThree-dimensional magnetic resonance angiographyDiagnosis of aneurysmConsecutive patientsAngiographyResonance angiographyMR examinationsGadopentetate dimeglumineReader B.DiseaseGradient echo sequenceConventional MRHepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector.
Earls J, Rofsky N, DeCorato D, Krinsky G, Weinreb J. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 1997, 202: 268-73. PMID: 8988222, DOI: 10.1148/radiology.202.1.8988222.Peer-Reviewed Original Research
1996
Breath-hold single-dose gadolinium-enhanced three-dimensional MR aortography: usefulness of a timing examination and MR power injector.
Earls J, Rofsky N, DeCorato D, Krinsky G, Weinreb J. Breath-hold single-dose gadolinium-enhanced three-dimensional MR aortography: usefulness of a timing examination and MR power injector. Radiology 1996, 201: 705-10. PMID: 8939219, DOI: 10.1148/radiology.201.3.8939219.Peer-Reviewed Original ResearchGadolinium-enhanced three-dimensional MR angiography of acquired arch vessel disease.
Krinsky G, Rofsky N, Flyer M, Giangola G, Maya M, DeCoroto D, Earls J, Weinreb J. Gadolinium-enhanced three-dimensional MR angiography of acquired arch vessel disease. American Journal Of Roentgenology 1996, 167: 981-7. PMID: 8819398, DOI: 10.2214/ajr.167.4.8819398.Peer-Reviewed Original ResearchAsymmetric signal intensity of the renal collecting systems as a sign of unilateral renal artery stenosis following administration of gadopentetate dimeglumine.
Walsh P, Rofsky N, Krinsky G, Weinreb J. Asymmetric signal intensity of the renal collecting systems as a sign of unilateral renal artery stenosis following administration of gadopentetate dimeglumine. Journal Of Computer Assisted Tomography 1996, 20: 812-4. PMID: 8797919, DOI: 10.1097/00004728-199609000-00025.Peer-Reviewed Original Research
1995
Ureteral lymphoma: MRI demonstration
Lebowitz J, Rofsky N, Weinreb J, Friedmann P. Ureteral lymphoma: MRI demonstration. Abdominal Radiology 1995, 20: 173-175. PMID: 7787726, DOI: 10.1007/bf00201532.Peer-Reviewed Original Research
1994
Effect on fetal mouse development of exposure to MR imaging and gadopentetate dimeglumine
Rofsky N, Pizzarello D, Weinreb J, Ambrosino M, Rosenberg C. Effect on fetal mouse development of exposure to MR imaging and gadopentetate dimeglumine. Journal Of Magnetic Resonance Imaging 1994, 4: 805-807. PMID: 7865940, DOI: 10.1002/jmri.1880040611.Peer-Reviewed Original ResearchMeSH KeywordsAnalysis of VarianceAnimalsBody WeightContrast MediaDrug CombinationsEar, ExternalEmbryonic and Fetal DevelopmentExtremitiesEyeFemaleFetal DeathGadoliniumGadolinium DTPAGestational AgeHeadLitter SizeMagnetic Resonance ImagingMeglumineMiceOrganometallic CompoundsPentetic AcidPregnancySodium ChlorideConceptsDays of gestationIntraperitoneal injectionGadopentetate dimeglumineFetal weightEnd pointMR exposureMean fetal weightSaline injection groupMagnetic resonance exposurePregnant miceNormal salineFetal mouse developmentGroup 2Group 1Group 3Control groupGroup 4Group 5MR imagingAdverse effectsDimeglumineSignificant differencesGestationFetusesInjectionSafety and optimum concentration of a manganese chloride–based oral MR contrast agent
Bernardino M, Weinreb J, Mitchell D, Small W, Morris M. Safety and optimum concentration of a manganese chloride–based oral MR contrast agent. Journal Of Magnetic Resonance Imaging 1994, 4: 872-876. PMID: 7865949, DOI: 10.1002/jmri.1880040620.Peer-Reviewed Original Research
1993
Quantitative analysis of gadopentetate dimeglumine excreted in breast milk
Rofsky N, Weinreb J, Litt A. Quantitative analysis of gadopentetate dimeglumine excreted in breast milk. Journal Of Magnetic Resonance Imaging 1993, 3: 131-132. PMID: 8428080, DOI: 10.1002/jmri.1880030122.Peer-Reviewed Original Research